Page last updated: 2024-10-25

deferiprone and Poisoning

deferiprone has been researched along with Poisoning in 5 studies

Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.

Poisoning: Used with drugs, chemicals, and industrial materials for human or animal poisoning, acute or chronic, whether the poisoning is accidental, occupational, suicidal, by medication error, or by environmental exposure.

Research Excerpts

ExcerptRelevanceReference
"Oral deferiprone holds promise in the treatment of iron poisoning in humans."5.31The efficacy of oral deferiprone in acute iron poisoning. ( Bentur, Y; Berkovitch, M; Klein, J; Koren, G; Livne, A; Lushkov, G; Segal, M; Talmor, C, 2000)
" The complete treatment of transfusional iron overload in thalassaemia using the deferiprone (L1) and deferoxamine combination is a paradigm to be followed in the treatment of many other metal toxicity conditions."3.79The proceedings of the 20th International Conference on Chelation held in the USA: advances on new and old chelation therapies. ( Kontoghiorghes, GJ, 2013)
"Oral deferiprone holds promise in the treatment of iron poisoning in humans."1.31The efficacy of oral deferiprone in acute iron poisoning. ( Bentur, Y; Berkovitch, M; Klein, J; Koren, G; Livne, A; Lushkov, G; Segal, M; Talmor, C, 2000)
"Deferiprone holds promise for the treatment of iron poisoning but additional study is required."1.29Efficacy of deferiprone in the treatment of acute iron intoxication in rats. ( Berkovitch, M; Cameron, RG; Daneman, N; Daneman, R; Falcitelli, C; Fassos, FF; Klein, J; Koren, G; Koren, L; St Louis, P, 1996)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aaseth, J1
Skaug, MA1
Cao, Y1
Andersen, O1
Kontoghiorghes, GJ2
Fassos, FF1
Berkovitch, M2
Daneman, N1
Koren, L1
Cameron, RG1
Klein, J2
Falcitelli, C1
St Louis, P1
Daneman, R1
Koren, G2
Livne, A1
Lushkov, G1
Segal, M1
Talmor, C1
Bentur, Y1

Reviews

2 reviews available for deferiprone and Poisoning

ArticleYear
Chelation in metal intoxication--Principles and paradigms.
    Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS), 2015, Volume: 31

    Topics: Administration, Oral; Antidotes; Benzoates; Chelating Agents; Deferasirox; Deferiprone; Deferoxamine

2015
Chemical, pharmacological, toxicological and therapeutic advances of deferiprone (L1) and other iron and aluminium chelators.
    Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement, 1996, Volume: 18

    Topics: Aluminum; Animals; Biotransformation; Chelating Agents; Deferiprone; Drug Design; Embryonic and Feta

1996

Other Studies

3 other studies available for deferiprone and Poisoning

ArticleYear
The proceedings of the 20th International Conference on Chelation held in the USA: advances on new and old chelation therapies.
    Toxicology mechanisms and methods, 2013, Volume: 23, Issue:1

    Topics: Chelating Agents; Chelation Therapy; Deferiprone; Deferoxamine; Edetic Acid; Humans; Iron Overload;

2013
Efficacy of deferiprone in the treatment of acute iron intoxication in rats.
    Journal of toxicology. Clinical toxicology, 1996, Volume: 34, Issue:3

    Topics: Animals; Deferiprone; Duodenum; Injections, Intraperitoneal; Iron; Iron Chelating Agents; Male; Pois

1996
The efficacy of oral deferiprone in acute iron poisoning.
    The American journal of emergency medicine, 2000, Volume: 18, Issue:1

    Topics: Acute Disease; Administration, Oral; Animals; Biological Availability; Deferiprone; Disease Models,

2000